Agilent Technologies to Acquire Assets of iLab Solutions
By LabMedica International staff writers Posted on 04 Jul 2016 |
Agilent Technologies Inc. (Santa Clara, California, USA) will acquire most of the assets of iLab Solutions, LLC (Boston, Massachusetts, USA), including the company’s technology, intellectual property, product portfolio and employee talent. The acquisition is expected to be completed in early August, subject to local laws and regulations and customary closing conditions.
Agilent provides instruments, software, services and consumables for the entire laboratory workflow to customers in more than 100 countries, while iLab offers cloud-based solutions for core laboratory management to universities, research hospitals and independent institutes. iLab’s offerings allow customers to book time in shared facilities to bill and invoice for projects, manage studies, generate reports and business intelligence, and schedule instrument reservations across multiple projects.
“Our acquisition of iLab further expands our offerings portfolio in a space we previously did not have a presence in,” said Mark Doak, president, Agilent CrossLab Group. “iLab’s solutions are robust and scalable, allowing for expansion into large-enterprise accounts, including Pharma. With iLab’s experience and outstanding enterprise-level management solutions, we will be able to immediately deliver broader value for our customers.”
“Joining forces with Agilent is an excellent fit for us,” said Tad Fallows, chief executive officer, iLab Solutions. “It is also a tremendous opportunity for our customers, who will benefit from integration with a broad family of solutions and a range of new applications. Together, we’ll be able to further accelerate our offerings to additional markets through Agilent’s global reach and leadership in multiple market segments.”
Related Links:
Agilent Technologies
iLab Solutions
Agilent provides instruments, software, services and consumables for the entire laboratory workflow to customers in more than 100 countries, while iLab offers cloud-based solutions for core laboratory management to universities, research hospitals and independent institutes. iLab’s offerings allow customers to book time in shared facilities to bill and invoice for projects, manage studies, generate reports and business intelligence, and schedule instrument reservations across multiple projects.
“Our acquisition of iLab further expands our offerings portfolio in a space we previously did not have a presence in,” said Mark Doak, president, Agilent CrossLab Group. “iLab’s solutions are robust and scalable, allowing for expansion into large-enterprise accounts, including Pharma. With iLab’s experience and outstanding enterprise-level management solutions, we will be able to immediately deliver broader value for our customers.”
“Joining forces with Agilent is an excellent fit for us,” said Tad Fallows, chief executive officer, iLab Solutions. “It is also a tremendous opportunity for our customers, who will benefit from integration with a broad family of solutions and a range of new applications. Together, we’ll be able to further accelerate our offerings to additional markets through Agilent’s global reach and leadership in multiple market segments.”
Related Links:
Agilent Technologies
iLab Solutions
Latest Industry News
- Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests
- CACLP 2025 New Date and Venue Announced
- Roche to Develop New Diagnostic Technologies for Traumatic Brain Injuries
- LGC Clinical Diagnostics and AccuGenomics Collaborate on Enhancing Cancer Testing Accuracy
- Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care
- Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
- Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance
- MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine
- Nova Biomedical and Terumo BCT Collaborate on Automated Cell Culture Sensing
- Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
- Roche Expands Digital Pathology Open Environment with Integration of Advanced AI Algorithms from New Collaborators
- Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications
- QIAGEN and AstraZeneca Expand Collaboration into New Disease Areas
- MEDICA 2024 + COMPAMED 2024: Adapted Hall Layout for Better Integration
- Global Coagulation Testing Driven by Increasing Blood Disorders and Surgical Interventions
- Sysmex and QIAGEN Expand Collaboration in Genetic Testing